Applications for nitric oxide in halting proliferation of tumor cells.

Tumor resistance to cytotoxic therapeutics coupled with dose-limiting toxicity is a serious hurdle in the field of medical oncology. In the face of this obstacle, nitric oxide has emerged as a powerful adjuvant for the hypersensitization of tumors to more traditional chemo- and radio-therapeutics. Furthermore, emerging evidence indicates that nitric oxide donors have the potential to function independently in the clinical management of cancer. Herein, we discuss the role of nitric oxide in cancer and the potential for nitric oxide donors to support conventional therapeutics.

[1]  P K Lala,et al.  Role of nitric oxide in carcinogenesis and tumour progression. , 2001, The Lancet. Oncology.

[2]  D. Bredt.  Endogenous nitric oxide synthesis: biological functions and pathophysiology. , 1999, Free radical research.

[3]  A. Ferro,et al.  Nitric oxide signalling in the regulation of cardiovascular and platelet function. , 2011, Frontiers in bioscience.

[4]  W. Xin,et al.  Production and interaction of oxygen and nitric oxide free radicals in PMA stimulated macrophages during the respiratory burst , 2000, Redox report : communications in free radical research.

[5]  Y. Kitamura,et al.  Nitric oxide donor-induced p53-sensitive cell death is enhanced by Bcl-2 reduction in human neuroblastoma cells , 1998, Neurochemistry International.

[6]  J. Albina,et al.  Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis , 1998, Cancer and Metastasis Reviews.

[7]  J. Yodoi,et al.  Overexpression of glutaredoxin protects cardiomyocytes against nitric oxide-induced apoptosis with suppressing the S-nitrosylation of proteins and nuclear translocation of GAPDH. , 2012, Biochemical and biophysical research communications.

[8]  W. Hiddemann,et al.  Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[9]  S. Kawanishi,et al.  Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide , 1995, FEBS letters.

[10]  A. Girotti,et al.  Chain-breaking Antioxidant and Cytoprotective Action of Nitric Oxide on Photodynamically Stressed Tumor Cells¶ , 2003, Photochemistry and photobiology.

[11]  F. Recchia,et al.  The role of nitric oxide in metabolism regulation: from basic sciences to the clinical setting , 2000, Intensive Care Medicine.

[12]  S. Macdonald-Goodfellow,et al.  Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling , 2007, Clinical Cancer Research.

[13]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[14]  C. Graham,et al.  Nitric oxide‐mediated regulation of hypoxia‐induced B16F10 melanoma metastasis , 2004, International journal of cancer.

[15]  Y. Cha,et al.  Heme oxygenase-1-mediated partial cytoprotective effect by NO on cadmium-induced cytotoxicity in C6 rat glioma cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  W. Freije,et al.  MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. , 2003, Cancer research.

[17]  Zhaoqing Wang,et al.  Protein S-nitrosylation and cancer. , 2012, Cancer letters.

[18]  C. Colton,et al.  Nitric oxide and redox mechanisms in the immune response , 2011, Journal of leukocyte biology.

[19]  B. Rigas.  Novel agents for cancer prevention based on nitric oxide. , 2007, Biochemical Society transactions.

[20]  S. Huerta,et al.  Nitric oxide donors: novel cancer therapeutics (review). , 1992 .

[21]  E. Ongini,et al.  Nitric Oxide‐Releasing Drugs , 2002 .

[22]  G. Chaudhuri,et al.  Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of cyclin D1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Xia,et al.  Inhibitory effects of nitric oxide on invasion of human cancer cells. , 2007, Cancer letters.

[24]  L. Keefer.  Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances , 2011, ACS chemical biology.

[25]  G. Thatcher,et al.  Nitrates and NO release: contemporary aspects in biological and medicinal chemistry. , 2004, Free radical biology & medicine.

[26]  G. Storme,et al.  Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. , 1998, Cancer research.

[27]  K. Yeung,et al.  Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. , 2008, Nitric oxide : biology and chemistry.

[28]  K. Kröncke.  Cysteine‐Zn2+ complexes: unique molecular switches for inducible nitric oxide synthase‐derived NO , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Bernhard Brüne,et al.  Nitric oxide: NO apoptosis or turning it ON? , 2003, Cell Death and Differentiation.

[30]  F. Ubeira,et al.  Respiratory burst responses of rat macrophages to microsporidian spores. , 2001, Experimental parasitology.

[31]  J. Dairou,et al.  Peroxynitrite Irreversibly Inactivates the Human Xenobioticmetabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1) in Human Breast Cancer Cells , 2004, Journal of Biological Chemistry.

[32]  Sujin Choi,et al.  Association of the ERK1/2 and p38 kinase pathways with nitric oxide-induced apoptosis and cell cycle arrest in colon cancer cells , 2005, Cell Biology and Toxicology.

[33]  Elena Forte,et al.  Cytochrome c oxidase and nitric oxide in action: molecular mechanisms and pathophysiological implications. , 2012, Biochimica et biophysica acta.

[34]  E. Cadenas,et al.  Nitric Oxide and Cell Signaling Pathways in Mitochondrial-Dependent Apoptosis , 2002, Biological chemistry.

[35]  J. Stamler,et al.  Regulation by S-Nitrosylation of Protein Post-translational Modification* , 2011, The Journal of Biological Chemistry.

[36]  H. Chakrapani,et al.  The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species , 2011, Journal of Pharmacology and Experimental Therapeutics.

[37]  D. Wink,et al.  The emergence of nitroxyl (HNO) as a pharmacological agent. , 2009, Biochimica et biophysica acta.

[38]  Anne Jarry,et al.  Position in Cell Cycle Controls the Sensitivity of Colon Cancer Cells to Nitric Oxide-Dependent Programmed Cell Death , 2004, Cancer Research.

[39]  K. Kröncke,et al.  Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where? , 1997, Nitric oxide : biology and chemistry.

[40]  R. Knight,et al.  S-nitrosylation regulates apoptosis , 1997, Nature.

[41]  S. Moncada.  Nitric oxide: discovery and impact on clinical medicine , 1999, Journal of the Royal Society of Medicine.

[42]  E. Chinje,et al.  Role of nitric oxide in growth of solid tumours: a balancing act. , 1997, Essays in biochemistry.

[43]  Melissa M. Reynolds,et al.  Enzymatically degradable nitric oxide releasing S-nitrosated dextran thiomers for biomedical applications , 2012 .

[44]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[45]  D. Hirst,et al.  Nitrosative stress as a mediator of apoptosis: implications for cancer therapy. , 2010, Current pharmaceutical design.

[46]  J. Kutok,et al.  JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells. , 2007, Blood.

[47]  A. Engin.  Dual function of nitric oxide in carcinogenesis, reappraisal. , 2011, Current drug metabolism.

[48]  V. Schirrmacher,et al.  Nitric oxide-induced apoptosis in tumor cells. , 2001, Advances in cancer research.

[49]  C. López-Pedrera,et al.  Nitric oxide and cancer: the emerging role of S-nitrosylation. , 2012, Current molecular medicine.

[50]  S. Ambs,et al.  Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer , 2012, Breast Cancer Research.

[51]  F. Tamanoi,et al.  Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer. , 2001, Cancer research.

[52]  D. Harrison,et al.  Reactive oxygen species and the control of vasomotor tone , 1999, Current hypertension reports.

[53]  P. Andreana,et al.  Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols. , 1999, Bioorganic & medicinal chemistry letters.

[54]  B. Mayer,et al.  Enzymatic function of nitric oxide synthases. , 1999, Cardiovascular research.

[55]  R. Farias-Eisner,et al.  Nitric oxide is an important mediator for tumoricidal activity in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Marletta,et al.  Structure and regulation of soluble guanylate cyclase. , 2012, Annual review of biochemistry.

[57]  J. Boucher,et al.  Reactivity of the heme–dioxygen complex of the inducible nitric oxide synthase in the presence of alternative substrates , 2006, The FEBS journal.

[58]  K. Arai,et al.  Protective action of nipradilol mediated through S-nitrosylation of Keap1 and HO-1 induction in retinal ganglion cells , 2012, Neurochemistry International.

[59]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[60]  E. Solary,et al.  Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. , 2002, Gastroenterology.

[61]  S. Colella,et al.  N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. , 2006, Carcinogenesis.

[62]  B. Bonavida,et al.  Nitric Oxide Donors Are a New Class of Anti-cancer Therapeutics for the Reversal of Resistance and Inhibition of Metastasis , 2010 .

[63]  Y. Kitamura,et al.  Possible involvement of ADP-ribosylation of particular enzymes in cell death induced by nitric oxide-donors in human neuroblastoma cells , 1997, Neurochemistry International.

[64]  C. Suschek,et al.  Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression , 2007, Oncogene.

[65]  M. N. Hughes.  Chemistry of nitric oxide and related species. , 2008, Methods in enzymology.

[66]  K. Isobe,et al.  Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. , 1999, Biochemical and biophysical research communications.

[67]  E. Ferreira,et al.  Nitric oxide: state of the art in drug design. , 2012, Current medicinal chemistry.

[68]  A. Gupta,et al.  Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies , 2011, Cancer Chemotherapy and Pharmacology.

[69]  Qiang Liu,et al.  Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines. , 2003, Carcinogenesis.

[70]  G. Storme,et al.  Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation , 1999, British Journal of Cancer.